Modern strategies in therapy of organophosphate poisoning

Toxicology Letters

Volumn 107, Issue 1-3, 1999, Pages 233-239

  Thiermann, H ^a   Szinicz, L ^a   Eyer, F ^b   Worek, F ^b   Eyer, P ^b   Felgenhauer, N ^c   Zilker, T ^c  

^a Inst fur Pharmakol und Toxikol   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Obidoxime; Organophosphate poisoning; Oxydemeton methyl; Parathion; Pralidoxime

Indexed keywords

ACETYLCHOLINESTERASE; ATROPINE; ERYTHROCYTE ENZYME; OBIDOXIME; ORGANOPHOSPHATE; OXYDEMETON METHYL; PARATHION; PRALIDOXIME; UNCLASSIFIED DRUG;

ADULT; BOLUS INJECTION; BRAIN INJURY; CLINICAL ARTICLE; CONFERENCE PAPER; CONTINUOUS INFUSION; CONTROLLED STUDY; DEATH; DRUG BLOOD LEVEL; ENZYME REACTIVATION; HUMAN; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; THEORY;

ACETYLCHOLINESTERASE; CHOLINESTERASE REACTIVATORS; ERYTHROCYTES; HUMANS; INSECTICIDES; OBIDOXIME CHLORIDE; ORGANOTHIOPHOSPHORUS COMPOUNDS; PARATHION;

EID: 0032994808     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(99)00052-1     Document Type: Conference Paper

References (23)

1. Besser R., Weilemann L., Gutman L. Efficacy of obidoxime in human organophosphate poisoning: determination by neuromuscular transmission studies. Muscle Nerve. 18:1995;15-22.
2. Casey P.B., Gosden E., Blakey L., Thompson J.P., Vale J.A. Plasma pralidoxime concentrations following bolus injection and continuous infusion. Przeg. Lek. 52:1995;203.
3. Casey P.B., Blakey L., Bradberry S.M., Vale J.A. Late reactivation of erythrocyte cholinesterase activity by pralidoxime in a case of chlorpyrifos poisoning. Przeg. Lek. 52:1995;206.
4. Eyer P. Optimal oxime dosage regimen, a pharmacokinetic approach. Szinicz L., Eyer P., Klimmek R. Role of Oximes in the Treatment of Anticholinesterase Agent Poisoning. 1996;33-51 Spektrum, Heidelberg.
5. Eyer, F., Eyer, P., 1998. Enzyme-based assay for quantification of paraoxon in blood of parathion poisoned patients. Hum. Exp. Toxicol. 17, 646-651.
6. Eyer P., Mast U. Pharmacokinetic aspects to improve oxime therapy in OP poisoning. Proceedings of the Second Chem. Biol. Med. Treatment Symposium, CH-Spiez. 1996;88-93.
7. Eyer F., Thiermann H., Worek F., Szinicz L., Eyer P. New aspects of parathion poisoning treatment. Naunyn-Schmiedeberg's Arch. Pharmacol. 358:1998;Suppl. R478.
8. Mast, U., 1997. Reaktivierung der Erythrozyten-Acetylcholinesterase durch Oxime. Thesis, München.
9. Medicis J.J., Stork C.M., Howland M.A., Hoffman R.S., Goldfrank L.R. Pharmacokinetics following a loading plus a continuous infusion of pralidoxime compared with the traditional short infusion regimen in human volunteers. Clin. Toxicol. 34:1996;289-295.
10. Pfab R., Felgenhauer N., Zilker T., Mast U., Thiermann H., Eyer P. Pharmacokinetics and laboratory findings during continuous infusion of obidoxime and atropine in a patient with severe oxydemeton methyl poisoning. Przeg. Lek. 52:1995;202-203.
11. Spöhrer U., Eyer P. Separation of geometrical syn/anti isomers of obidoxime by ion-pair high-performance liquid chromatography. J. Chromatogr. A. 693:1995;55-61.
12. Sundwall A. Minimum concentrations of N-methyl-pyridinium-2-aldoxime methanesulphonate (P2S) which reverse neuromuscular block. Biochem. Pharmacol. 8:1961;413-417.
13. Taitelman U. Round table discussion. Szinicz L., Eyer P., Klimmek R. Role of Oximes in the Treatment of Anticholinesterase Agent Poisoning. 1996;78 Spektrum, Heidelberg.
14. Thiermann H., Radtke M., Spöhrer U., Klimmek R., Eyer P. Pharmacokinetics of atropine in dogs after i.m. injection with newly developed dry/wet combination autoinjectors containing HI 6 or HLö 7. Arch. Toxicol. 70:1996;293-299.
15. Thiermann H., Mast U., Klimmek R., Eyer P., Hibler A., Pfab R., Felgenhauer N., Zilker T. Cholinesterase status, pharmakokinetics and laboratory findings during obidoxime therapy in organophosphate poisoned patients. Hum. Exp. Toxicol. 16:1997;473-480.
16. Vale J.A. Oximes-useless and harmful? Przeg. Lek. 52:1995;201.
17. Vale J.A. Rationale for oxime therapy: pralidoxime as an antidote in OP insecticide poisoning. Hum. Exp. Toxicol. 15:1996;77.
18. Willems J.L. Cholinesterase reactivation in organophosphorus poisoned patients depends on the plasma concentration of the oxime pralidoxime methylsulphate in the treatment of the organophosphate poisoning. Arch. Toxicol. 67:1993;79-84.
19. Willems J.L. Pralidoxime methylsulfate in the treatment of organophosphorus poisoning. Szinicz L., Eyer P., Klimmek R. Role of Oximes in the Treatment of Anticholinesterase Agent Poisoning. 1996;69-73 Spektrum, Heidelberg.
20. Worek F., Bäcker M., Thiermann H., Szinicz L., Mast U., Klimmek R., Eyer P. Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning. Hum. Exp. Toxicol. 16:1997;466-472.
21. Worek, F., Diepold, C., Eyer, P., 1999. Dimethylphosphoryl-inhibited human cholinesterases: inhibition, reactivation, and aging kinetics. Arch. Toxicol. 73, 7-14.
22. Zilker T., Hibler A. Treatment of severe parathion poisoning. Szinicz L., Eyer P., Klimmek R. Role of Oximes in the Treatment of Anticholinesterase Agent Poisoning. 1996;9-17 Spektrum, Heidelberg.
23. Zilker T., Felgenhauer N., Hibler A., Pfab R., Thiermann H., Worek F., Eyer P. Factors influencing the efficacy of obidoxime in organophosphate pesticide poisoning. Przeg. Lek. 54:1997;662-664.